Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Douglas R. Adkins, Katie M. Campbell et al.|Clinical Cancer Research|2020Cited by 368
Vestibular Dysfunction after Cochlear ImplantationManuela Fina, J. Gail Neely, Margaret W. Skinner et al.|Otology & Neurotology|2003Cited by 183
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancerGiacomo Oliveira, Ravindra Uppaluri, Ann Marie Egloff et al.|Science Immunology|2023Cited by 118
Onyx embolization for dural arteriovenous fistulas: a multi-institutional studyYangchun Li, Robert M. Starke, Diederik Bulters et al.|Journal of NeuroInterventional Surgery|2021Cited by 42
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Douglas R. Adkins, Katie M. Campbell et al.|Clinical Cancer Research|2021Cited by 14